These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1791467)

  • 1. The interaction of hydroxypyridinones with human serum transferrin and ovotransferrin.
    Stefanini S; Chiancone E; Cavallo S; Saez V; Hall AD; Hider RC
    J Inorg Biochem; 1991 Oct; 44(1):27-37. PubMed ID: 1791467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrins. Hen ovo-transferrin, interaction with bicarbonate and iron uptake.
    Bou Abdallah F; el Hage Chahine JM
    Eur J Biochem; 1998 Dec; 258(3):1022-31. PubMed ID: 9990321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative oxidations of tyrosines and methionines in transferrins: human serum transferrin, human lactotransferrin, and chicken ovotransferrin.
    Penner MH; Yamasaki RB; Osuga DT; Babin DR; Meares CF; Feeney RE
    Arch Biochem Biophys; 1983 Sep; 225(2):740-7. PubMed ID: 6312890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrins, the mechanism of iron release by ovotransferrin.
    Abdallah FB; Chahine JM
    Eur J Biochem; 1999 Aug; 263(3):912-20. PubMed ID: 10469158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
    J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies on the removal of iron and aluminum from recombinant and site-directed mutant N-lobe half transferrins.
    Li Y; Harris WR; Maxwell A; MacGillivray RT; Brown T
    Biochemistry; 1998 Oct; 37(40):14157-66. PubMed ID: 9760252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron mobilization from transferrin by therapeutic iron chelating agents.
    Evans RW; Kong X; Hider RC
    Biochim Biophys Acta; 2012 Mar; 1820(3):282-90. PubMed ID: 22155077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD; Evans RW; Evans PJ; Hider RC
    Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of iron from transferrin by phosphonocarboxylate and diphosphonate chelating agents.
    Harris WR; Brook CE; Spilling CD; Elleppan S; Peng W; Xin M; Wyk JV
    J Inorg Biochem; 2004 Nov; 98(11):1824-36. PubMed ID: 15522410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodate modification of human serum transferrin Fe(III)-binding sites. Inhibition of carbonate insertion into Fe(III)- and Cu(II)-chelator-transferrin ternary complexes.
    Ross DC; Egan TJ; Purves LR
    J Biol Chem; 1995 May; 270(21):12404-10. PubMed ID: 7759481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calorimetric studies of serum transferrin and ovotransferrin. Estimates of domain interactions, and study of the kinetic complexities of ferric ion binding.
    Lin LN; Mason AB; Woodworth RC; Brandts JF
    Biochemistry; 1994 Feb; 33(7):1881-8. PubMed ID: 8110792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive binding of iron by transferrins from different vertebrates.
    Jarritt PH; Charlwood PA
    Biochim Biophys Acta; 1976 Dec; 453(2):319-31. PubMed ID: 11826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron removal from monoferric human serum transferrins by 1, 2-dimethyl-3-hydroxypyridin-4-one, 1-hydroxypyridin-2-one and acetohydroxamic acid.
    Li Y; Harris WR
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):89-102. PubMed ID: 9748517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt and the iron acquisition pathway: competition towards interaction with receptor 1.
    Chikh Z; Hémadi M; Miquel G; Ha-Duong NT; El Hage Chahine JM
    J Mol Biol; 2008 Jul; 380(5):900-16. PubMed ID: 18579154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of chelating agents on iron mobilization in Chang cell cultures.
    White GP; Jacobs A; Grady RW; Cerami A
    Blood; 1976 Dec; 48(6):923-9. PubMed ID: 1000084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two procedures used for complexing Fe(III) with human apotransferrin. II. Uptake of Fe(III) by K-562 cells from 55Fe . transferrins and Fe . [3H]transferrins.
    Hatton MW; Berry LR
    Biochem Cell Biol; 1987 Apr; 65(4):271-9. PubMed ID: 3606854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethoxyformylation and photooxidation of histidines in transferrins.
    Rogers TB; Gold RA; Feeney RE
    Biochemistry; 1977 May; 16(10):2299-305. PubMed ID: 558796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anion binding properties of the transferrins. Implications for function.
    Harris WR
    Biochim Biophys Acta; 2012 Mar; 1820(3):348-61. PubMed ID: 21846492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates.
    Turcot I; Stintzi A; Xu J; Raymond KN
    J Biol Inorg Chem; 2000 Oct; 5(5):634-41. PubMed ID: 11085654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin and iron uptake by rat hepatocytes in culture.
    Page MA; Baker E; Morgan EH
    Am J Physiol; 1984 Jan; 246(1 Pt 1):G26-33. PubMed ID: 6141733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.